An efficacy study of RHB-104 in newly diagnosed and the treatment-naïve Crohn's disease patients.
Phase of Trial: Phase II/III
Latest Information Update: 27 Oct 2016
At a glance
- Drugs Clarithromycin/clofazimine/rifabutin (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- 27 Oct 2016 New trial record
- 07 Oct 2016 According to a RedHill media release this study along with other study (CTP-700277883) will provide additional supportive clinical data to potential future marketing applications.